Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bupivacaine in Tibial Plateau Fractures
NCT06474949Phase 4Not yet recruiting
- Sponsor
- University of Washington
- Start
- Aug 2024
- Primary completion
- Aug 2026
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of bupivacaine in tibial plateau fracture, sponsored by University of Washington. Planned start Aug 2024; status: not yet recruiting.
02
Drugs
bupivacaine
03
Conditions
tibial plateau fracture
Beyond the preview
Go deeper on NCT06474949.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06474949.